Back

Echinocandin heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infection

Zhai, B.; Liao, C.; Jaggavarapu, S.; Rolling, T.; Bergin, S. A.; Gjonbalaj, M.; Miranda, E.; Babady, N. E.; Butler, G.; Taur, Y.; Xavier, J. B.; Weiss, D.; Hohl, T.

2022-05-29 infectious diseases
10.1101/2022.05.29.22275734 medRxiv
Show abstract

Breakthrough infections of patients on antimicrobial prophylaxis represent a significant and often unexplained cause of morbidity. Here, we reveal that in high-risk patients on micafungin prophylaxis heteroresistance - the presence of a phenotypically unstable, low frequency subpopulation of resistant cells ([~]1 in 10,000) - underlies breakthrough bloodstream infections by Candida parapsilosis misclassified as susceptible by standard antimicrobial susceptibility testing. By analyzing 219 clinical C. parapsilosis isolates from North America, Europe, and Asia, we demonstrate widespread micafungin heteroresistance. To facilitate detection of micafungin heteroresistance, we constructed a predictive machine learning framework that classifies isolates as heteroresistant or susceptible by a maximum of ten genomic features. Our results connect heteroresistance to unexplained prophylaxis failure and demonstrate a proof-of-principle diagnostic approach with the potential to inform clinical decisions.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Science Translational Medicine
111 papers in training set
Top 0.1%
21.4%
2
Nature Communications
4913 papers in training set
Top 16%
11.7%
3
Immunity
58 papers in training set
Top 0.8%
6.5%
4
Nature Medicine
117 papers in training set
Top 0.4%
6.0%
5
Cell
370 papers in training set
Top 3%
6.0%
50% of probability mass above
6
Science
429 papers in training set
Top 7%
4.6%
7
Nature
575 papers in training set
Top 6%
4.0%
8
Cell Host & Microbe
113 papers in training set
Top 2%
3.4%
9
Cancer Discovery
61 papers in training set
Top 0.7%
3.4%
10
Journal of Clinical Investigation
164 papers in training set
Top 1%
3.4%
11
Nature Microbiology
133 papers in training set
Top 1%
2.9%
12
EMBO Molecular Medicine
85 papers in training set
Top 1.0%
2.5%
13
Nature Genetics
240 papers in training set
Top 4%
2.0%
14
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 29%
2.0%
15
Science Advances
1098 papers in training set
Top 17%
1.7%
16
eLife
5422 papers in training set
Top 44%
1.6%
17
JCI Insight
241 papers in training set
Top 4%
1.4%
18
mBio
750 papers in training set
Top 9%
1.2%
19
Genome Medicine
154 papers in training set
Top 7%
0.9%
20
The Journal of Infectious Diseases
182 papers in training set
Top 4%
0.8%
21
Science Immunology
81 papers in training set
Top 2%
0.7%
22
Cell Reports
1338 papers in training set
Top 33%
0.7%
23
Nature Biotechnology
147 papers in training set
Top 8%
0.7%
24
Cell Reports Medicine
140 papers in training set
Top 9%
0.7%
25
Nature Biomedical Engineering
42 papers in training set
Top 2%
0.7%
26
Nature Immunology
71 papers in training set
Top 2%
0.7%
27
Scientific Reports
3102 papers in training set
Top 79%
0.6%